Funding for this research was provided by:
Российский Фонд Фундаментальных Исследований (19-015-00122)
Received: 15 July 2020
Accepted: 16 July 2020
First Online: 22 October 2020
Ethics approval and consent to participate
: The clinical and molecular genetic study was performed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Federal State Budgetary Institution “Research Centre for Medical Genetics,” Moscow, Russia, with written informed consent obtained from each participant and/or their legal representative as appropriate.
: Consent for publication was obtained from the legal guardian of the patient.
: The authors declare that they have no competing interests.